Literature DB >> 5043415

Lack of distinctive surface antigen on cells transformed by murine sarcoma virus.

V Strouk, G Grundner, E M Fenyö, E Lamon, H Skurzak, G Klein.   

Abstract

Some murine sarcoma virus (MSV)-transformed mouse 3T3 cells contain the MSV genome in the absence of infectious helper murine leukemia virus (MuLV) and MSV production. These cells, designated S+L- (sarcoma positive, leukemia negative), were analyzed for the presence of a possible MSV-determined membrane antigen by the mixed hemadsorption test and in vitro lymphocyte cytotoxicity assay. Two different serological approaches were used: (a) isoantibody-free sera were obtained by immunizing with MSV of syngeneic origin or by allowing primary, autologous MSV sarcomas to regress, or (b) alloantisera obtained by immunizing C57BL mice with S+L- cells were absorbed with the corresponding nontransformed 3T3 cells until all activity against 3T3 had been removed. While MuLV-superinfected S+L- cells and a culture line of an MSV sarcoma known to produce both MSV and MLV were highly reactive, normal 3T3 and S+L- cells were negative. Similarly, lymph node cells from MSV immune mice or rats did not kill S+L- cells, although they were cytotoxic against target cells known to carry MuLV-associated antigens. Thus, the present study gives no positive evidence for the existence of any MSV-induced new surface antigen in the transformed target cell, known to carry the viral genome.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5043415      PMCID: PMC2139205          DOI: 10.1084/jem.136.2.344

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Tissue culture assay for Moloney leukemia virus.

Authors:  B O Nordenskjöld; E Klein; T Tachibana; E M Fenyö
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  Antigenicity of a virus-induced murine sarcoma (Moloney).

Authors:  A Fefer; J L McCoy; J P Glynn
Journal:  Cancer Res       Date:  1967-05       Impact factor: 12.701

3.  A theory on the mechanism of carcinogenesis by small deoxyribonucleic acid tumour viruses.

Authors:  L Sachs
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

4.  A virus-induced rhabdomyosarcoma of mice.

Authors:  J B Moloney
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

5.  The presence of Moloney virus induced antigen on antibody-producing cells.

Authors:  F Celada; B Asjö; G Klein
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

6.  Studies on Murine Sarcoma Virus: antigenic characterization of Murine Sarcoma Virus induced tumor cells.

Authors:  J C Chuat; L Berman; P Gunvén; E Klein
Journal:  Int J Cancer       Date:  1969-07-15       Impact factor: 7.396

7.  Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. I. Biologic and immunogenic studies.

Authors:  L W Law; R C Ting; M F Stanton
Journal:  J Natl Cancer Inst       Date:  1968-05       Impact factor: 13.506

8.  A microassay for cell-mediated immunity.

Authors:  M Takasugi; E Klein
Journal:  Transplantation       Date:  1970-03       Impact factor: 4.939

Review 9.  Tumor antigens.

Authors:  G Klein
Journal:  Annu Rev Microbiol       Date:  1966       Impact factor: 15.500

10.  An electron microscopic study of a virus-induced murine sarcoma (Moloney).

Authors:  A J Dalton
Journal:  Natl Cancer Inst Monogr       Date:  1966-09
View more
  12 in total

1.  Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy.

Authors:  T Aoki; J R Stephenson; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

2.  Helper-dependent properties of Friend spleen focus-forming virus: effect of the Fv-1 gene on the late stages in virus synthesis.

Authors:  R J Eckner
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

3.  Surface antigens of mammalian sarcoma virus-transformed nonproducer cells.

Authors:  T Aoki; J R Stephenson; S A Aaronson; K C Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

4.  The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection.

Authors:  E W Lamon; H Wigzel; E Klein; B Andersson; H M Skurzak
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

5.  In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.

Authors:  E W Lamon; H M Skurzak; E Klein; H Wigzell
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

6.  IgM-induced tumor cell cytotoxicity mediated by normal thymocytes.

Authors:  E W Lamon; H D Whitten; B Lidin; H H Fudenberg
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

7.  Nonproducer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma.

Authors:  E Weiland; M Mussgay; F Weiland
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

8.  Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.

Authors:  D B Jones; M Moore
Journal:  Br J Cancer       Date:  1974-02       Impact factor: 7.640

9.  Tumour-associated transplantation antigens of neoplasms induced by a naturally occurring murine sarcoma virus (FBJ-MSV).

Authors:  D B Jones; M Moore
Journal:  Br J Cancer       Date:  1973-06       Impact factor: 7.640

10.  Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.

Authors:  L Chieco-Bianchi; A Colombatti; D Collavo; F Sendo; T Aoki; P J Fischinger
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.